Table 1.
Patient characteristics by use of Colyte® and MoviPrep®.
Table 2.
Association of covariates with outcomes in multivariable analysis.
Fig 1.
MoviPrep® was associated with a small increase in the odds* of having a suboptimal bowel prep but was not associated with patients receiving a recommendation for an early repeat colonoscopy.
*Adjusted for age, gender, fellow participation, the individual endoscopist, insurance provider, chronic pain diagnosis, opioid use, interpreter needed, and whether the colonoscopy was for a diagnostic or screening/surveillance indication.
Fig 2.
The adenoma detection rate* and the advanced adenoma detection rate* were similar for procedures using Colyte® compared to MoviPrep®.
*Adjusted for age, gender, fellow participation, the individual endoscopist, insurance provider, chronic pain diagnosis, opioid use, interpreter needed, and whether the colonoscopy was for a diagnostic or screening/surveillance indication.
Fig 3.
Total procedure times*, insertion times*, and withdrawal times* were similar for procedures using MoviPrep® compared to Colyte®.
*Adjusted for age, gender, fellow participation, the individual endoscopist, insurance provider, chronic pain diagnosis, opioid use, interpreter needed, total number of polyps, the size of the largest polyp, and whether the colonoscopy was for a diagnostic or screening/surveillance indication. Error bars reflect 95% confidence intervals.